Publications by authors named "Ohad Amit"

Claim this Profile
O
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net.
Marlieke E A de Kraker, Harriet Sommer, Femke de Velde, Isaac Gravestock, Emmanuel Weiss, Ohad Amit

Clin Infect Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinded independent central review of the progression-free survival endpoint.
Ohad Amit, Will Bushnell, Lori Dodd, Nancy Roach, Daniel Sargent

Oncologist· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graphical approaches to the analysis of safety data from clinical trials.
Ohad Amit, Richard M Heiberger, Peter W Lane

Pharm Stat· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
Stephen I Rennard, Neil Schachter, Mary Strek, Kathy Rickard, Ohad Amit

Chest· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease.
Elizabeth Gamble, Diana C Grootendorst, Christopher E Brightling, Susannah Troy, Yusheng Qiu, Ohad Amit

Am J Respir Crit Care Med· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis